Ticker Details
C4 Therapeutics, Inc.
IPO Date:	October 2, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$276.15M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.45 | 3.96%
Avg Daily Range (30 D):	$0.13 | 4.72%
Avg Daily Range (90 D):	$0.10 | 4.06%

Institutional Daily Volume
Avg Daily Volume:	1.49M
Avg Daily Volume (30 D):	2.9M
Avg Daily Volume (90 D):	2.04M

Trade Size
Avg Trade Size (Sh.):	153
Avg Trade Size (Sh.) (30 D):	180
Avg Trade Size (Sh.) (90 D):	201

Institutional Trades
Total Institutional Trades:	1,065
Avg Institutional Trade:	$1.96M
Avg Institutional Trade (30 D):	$1.44M
Avg Institutional Trade (90 D):	$3.26M
Avg Institutional Trade Volume:	.23M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.18M
Avg Closing Trade (30 D):	$.83M
Avg Closing Trade (90 D):	$1.38M
Avg Closing Volume:	188.78K

News

Feb 4, 2026 @ 12:00 PM C4 Therapeutics to Participate in the Guggenheim E... Source: Na

Jan 14, 2026 @ 12:00 PM C4 Therapeutics Outlines Strategic Milestones to A... Source: C4 Therapeutics, Inc.

Nov 25, 2025 @ 12:00 PM C4 Therapeutics to Participate in the 8th Annual E... Source: C4 Therapeutics

Sep 15, 2025 @ 10:33 PM Why C4 Therapeutics Stock Crushed the Market on Mo... Source: Eric Volkman

May 7, 2025 @ 11:00 AM C4 Therapeutics Reports First Quarter 2025 Financi... Source: C4 Therapeutics

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.27	$-.09	$-1.27
Diluted EPS	$-1.27	$-.09	$-1.27
Revenue	$35.95M	$11.02M	$35.95M
Gross Profit
Net Income / Loss	$-104.99M	$-20.49M	$-104.99M
Operating Income / Loss	$-115.22M	$-23.15M	$-115.22M
Cost of Revenue
Net Cash Flow	$19.1M	$15.79M	$19.1M
PE Ratio